Clearly, given the importance of these actors in the current search for new cancer therapies, especially in combination with anti-PD-1/PD-L1 strategies, there is a crucial need for information regarding their presence on exosomes and their impact on resistance to therapy. Here, PDCD1 is linked to cancer.